The University of Texas Medical Branch, Galveston

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, The University of Texas Medical Branch, Galveston sits in the top decile of US sponsors by registered trial count (#152 of 15,742 sponsors by registered trial count).

203 total trials 29 currently recruiting 117 completed early-phase tilt top decile by trial count

The University of Texas Medical Branch, Galveston: 203 sponsored US clinical trials, 29 recruiting.

The University of Texas Medical Branch, Galveston sponsors 203 registered US clinical trials on ClinicalTrials.gov, 29 of them currently recruiting, and 117 completed. 19 of these trials are in Phase 3-4 (later-stage) and 51 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 4 trials.

Top-decile sponsor footprint

The University of Texas Medical Branch, Galveston ranks in the top decile of sponsors by registered trial count (#152 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 25/100

117 of 157 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (74.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

203 total, page 3 of 5

COMPLETED NA

Quantitative Sensory Testing in Chronic Pain Patients Undergoing Opioid Treatment and Opioid Tapering

NCT03375216
COMPLETED

Validation of a Novel Screening Test for Maternal Insulin Resistance

NCT03388697
TERMINATED Phase 3

Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide

NCT03298802
COMPLETED NA

Effect of Whey Protein Hydrolysate on Human Muscle Protein Synthesis

NCT03313830
COMPLETED NA

Measurement of Hemodynamic Variables Under Spinal Anesthesia With Varied Positioning

NCT02883075
COMPLETED Phase 1

Prophylactic Antibiotics After Cesarean

NCT03187106
COMPLETED NA

Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy

NCT03044197
COMPLETED Phase 1

The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment

NCT02553603
COMPLETED

Non-invasive Spot Hemoglobin Measurement in the Outpatient Obstetric Clinic

NCT03175042
COMPLETED NA

Identifying Therapeutic Targets of Accelerated Sarcopenia

NCT03118050
COMPLETED NA

Continuous Non-Invasive Measurement of Hemoglobin During Parturition

NCT03150043
COMPLETED NA

Physician Attire and Appreciation of Physician Communication in Postpartum Women

NCT03403660
COMPLETED Phase 2

Esmolol vs. Labetalol in Endoscopic Sinus Surgery

NCT03661346
TERMINATED Phase 3

Treatment of ppROM With Erythromycin vs. Azithromycin Trial

NCT03060473
TERMINATED

Mitochondrial Respiratory Function in Mammalian Skeletal Muscle

NCT02650570
TERMINATED Phase 2

Does a Rescue Course of Betamethasone in Pregnant Women With PPROM Decrease Neonatal Morbidity?

NCT02939742
TERMINATED Early Phase 1

Low-Cost Imaging for Cervical Cancer Prevention in the Texas Lower Rio Grande Valley

NCT02714439
COMPLETED Phase 4

Multimodal Pain Management for Cesarean Delivery

NCT02922985
COMPLETED Phase 1

Muscle Anabolic Interventions to Accelerate Recovery From Hospitalization in Geriatric Patients

NCT02990533
COMPLETED NA

Induction of Labor in Women With Unfavorable Cervix: Dilapan Versus Foley Bulb

NCT02899689
COMPLETED NA

Physical Exercise and Contributors to Academic Performance Among Adolescents With ASD (Fit Club Study)

NCT03934879
COMPLETED NA

Music and/or Video Games During Labor

NCT03024411
COMPLETED NA

Pink Warrior-Support Group Toolkit for Breast Cancer Survivors

NCT02750241
TERMINATED Early Phase 1

Cycled Testosterone Therapy to Improve Physical Function in Frail Nursing Home Residents

NCT02679274
COMPLETED NA

TAME Health: Testing Activity Monitors' Effect on Health

NCT02554435
COMPLETED Phase 2

Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients

NCT03038594
TERMINATED Phase 2

Fenofibrate and Propranolol in Burn Patients

NCT02452255
TERMINATED Phase 2

Panhematin for Prevention of Acute Attacks of Porphyria

NCT02922413
COMPLETED NA

Nutrient Sensing & Signaling in Aging Muscle

NCT02999802
COMPLETED

Indomethacin PK and PD Therapy in Pregnancy

NCT02451228
TERMINATED

Identification and Validation of Biomarkers for Infections in Burns

NCT02457663
COMPLETED NA

Impact of Timing of Wound Dressing Removal After Cesarean Section

NCT02445729
COMPLETED NA

Self-monitoring Activity: a Randomized Trial of Game-oriented Applications

NCT02341235
COMPLETED

Prevalence of Malnutrition and/or Sarcopenia at Hospital Admission

NCT02990520
COMPLETED NA

Cognitive Behavioral Therapy for Insomnia and Nocturnal Hot Flashes in Menopause

NCT02092844
COMPLETED Phase 1

Growth Hormone or Sildenafil as Therapies for Fatigue in Mild- Traumatic-brain-injury (MTBI)

NCT02114775
COMPLETED

The Life Participation for Parents as an Outcome Measure

NCT02921958
COMPLETED NA

Effect of In-Patient Exercise Training on Length of Hospitalization in Burned Patients

NCT02739464
COMPLETED NA

STEP AND GO: A Study of Technology-based Exercise Promotion

NCT01953224
COMPLETED NA

IMPACT: Inactivity Monitoring and Physical Activity Controlled Trial

NCT01869348
TERMINATED

Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma

NCT02487394
COMPLETED Phase 2

Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria

NCT02180412
COMPLETED NA

Virtual Reality Analgesia for Pediatric Burn Survivors

NCT03491657
TERMINATED Phase 2

Propranolol in Severely Burned Children

NCT01957449
COMPLETED NA

Comparative Efficacy of the Masquelet Versus Titanium Mesh Cage Techniques for the Treatment of Large Long Bone Defects

NCT02015390
COMPLETED Phase 1

Feasibility Study of Post-hospitalization Interventions to Improve Physical Function in Older Adults

NCT02203656
TERMINATED Phase 2

Protective Effects of Propranolol in Adults

NCT01902810
TERMINATED Phase 4

Hormonal Status on Blood Flow and Tissue in Pelvic Organ Prolapse

NCT01886794
TERMINATED Phase 4

Fatty Liver Study in Patients With Type II Diabetes

NCT02365233
COMPLETED Phase 2

Vitamin E Supplementation in Burned Patients

NCT01749371
← Previous Page 3 of 5 Next →

Phase Distribution

PhaseTrial count
Phase 1 24
Phase 2 27
Phase 3 4
Phase 4 15

Therapeutic Areas

Stroke 4
Cancer 4
Diabetes 3
Urinary Incontinence 3
Diabetes Mellitus, Type 2 3
Asthma 3
Breast Cancer 3
Burns 2
Cardiovascular Disease 2
Burn Injury 2

What is open in the The University of Texas Medical Branch, Galveston pipeline

29 recruiting of 203 indexed (14% open); 117 completed (58%).

Phase mix: 19 late (III/IV) vs 51 early (I/II) (early-phase heavy).

Top condition: Stroke (4 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

The University of Texas Medical Branch, Galveston: open-pipeline peers nationwide

Peers matched on 203 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

The University of Texas Medical Branch, Galveston sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 050100150200250 0%5%10%15%20% Total trials Recruiting share The University of Texas Medical Branch, GalvestonNational Center for Complementary and Integrative Health (NCCIH)MedImmuneGenzyme, a Sanofi CompanyOHSU Knight Cancer InstituteAcademic and Community Cancer Research UnitedAdaptive BiotechnologiesAgelessRxAlaska Blind Child Discovery
The University of Texas Medical Branch, Galveston sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

The University of Texas Medical Branch, Galveston sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 203 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this The University of Texas Medical Branch, Galveston page

203 registered trials is a research-attention snapshot, not an endorsement of The University of Texas Medical Branch, Galveston or any single study.

  • 29 of The University of Texas Medical Branch, Galveston's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Stroke is the condition The University of Texas Medical Branch, Galveston studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

The University of Texas Medical Branch, Galveston pipeline card: 203 registered trials from official public datasets.Report a data error.